Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01746251
Title Adjuvant Afatinib in Stage I-III NSCLC With EGFR Mutation
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.